THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL;THE ROYAL MARSDEN NHS FOUNDATION TRUST
发明人:
BANERJI, UDAI,班纳吉 马岱,班納吉 馬岱
申请号：
TW107116587
公开号：
TW201922254A
申请日:
2018.05.16
申请国别(地区):
TW
年份:
2019
代理人:
摘要：
The present invention provides a medicament for the treatment or prevention of a cell proliferative disorder, the medicament comprising as an active ingredient a compound represented by formula (I): or a pharmaceutically acceptable salt thereof, wherein the medicament is used in such a manner that: (a) said compound or salt is administered twice weekly for 3 weeks, (b) administration of said compound or salt is paused for the following 1 week, and (c) steps (a) and (b) are subsequently repeated at least once.本發明提供一種用於治療或預防細胞增殖性病症的藥物，前述藥物包含式(I)所示之化合物：或其醫藥上可接受的鹽作為活性成分，其中前述藥物以下述方式使用：(a)每週兩次投予所述化合物或鹽，持續3週，(b)在接下來的1週暫停投予所述化合物或鹽，以及(c)隨後重複步驟(a)和(b)至少一次。
